About KindredBio
KindredBio is a company based in Burlingame (United States) founded in 2012 was acquired by Elanco in June 2021. KindredBio has raised $6.9 million across 3 funding rounds from investors including Elanco and SLR Investment Corp. The company has 64 employees as of December 31, 2022. KindredBio operates in a competitive market with competitors including Zoetis, Ceva, PetMedix, QBiotics and Hester Biosciences, among others.
- Headquarter Burlingame, United States
- Employees 64 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kindred Biosciences, Inc.
-
Annual Revenue
$42.16 M (USD)891as on Dec 31, 2020
-
Net Profit
-$21.8 M (USD)64as on Dec 31, 2020
-
EBITDA
-$19.97 M (USD)68as on Dec 31, 2020
-
Total Equity Funding
$6.9 M (USD)
in 3 rounds
-
Latest Funding Round
$50 M (USD), Debt – Conventional
Oct 02, 2019
-
Investors
Elanco
& 1 more
-
Employee Count
64
as on Dec 31, 2022
-
Acquired by
Elanco
(Jun 16, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of KindredBio
Unlock access to complete
Unlock access to complete
Software Development Team
206 people
Leadership Team
81 people
Sales and Marketing
63 people
Finance and Accounting
48 people
Human Resources and Administration
37 people
Senior Team
31 people
Legal and Compliance
23 people
Product Management Team
23 people
Unlock access to complete
Funding Insights of KindredBio
KindredBio has successfully raised a total of $6.9M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $50 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in KindredBio
KindredBio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Elanco and SLR Investment Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Debt and equity investments are offered by the firm.
|
Locked | Locked | Locked | |
|
Veterinary food and medicines products are provided for animal health.
|
Locked | Locked | Locked |
Investor details for KindredBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KindredBio
Investment portfolio details for KindredBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - KindredBio
Detailed financials for KindredBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kindredbio Comparisons
Peer comparison for KindredBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KindredBio
KindredBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, PetMedix, QBiotics and Hester Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| Locked | Locked | Locked |
Developer of monoclonal antibody therapeutics for pets
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Manufacturer of animal vaccines and healthcare products
|
|
| Locked | Locked | Locked |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
Detailed competitors of KindredBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kindredbio
Complete news archive for KindredBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KindredBio
KindredBio was founded in 2012.
KindredBio is headquartered in Burlingame, United States. It is registered at Burlingame, California, United States.
KindredBio is a funded company, having raised a total of $6.9M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at KindredBio is 64.
Annual revenue of KindredBio is $42.16M as on Dec 31, 2020.
Kindred Biosciences was founded in 2012 and is headquartered in Burlingame, United States. Operations are centered on veterinary biotechnology, with a focus on antibody-based therapies for animal diseases. Treatments targeting conditions in cats, dogs, and horses have been developed by the company. Activities encompass research and development within the animal health sector, supporting therapeutic advancements for companion and equine species.
KindredBio has 2 investors. Key investors include Elanco, and SLR Investment Corp.